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Abstract
Background—To guide resource allocation, policy makers need evidence of the cost-
effectiveness of interventions. We summarized such evidence on selected interventions to reduce 
sodium intake that would be intended as population-wide approaches to control hypertension.
Methods—We conducted a comprehensive literature review of journal articles published in 
English from January 2000 to May 2010 by searching the databases of PubMed, EMBASE, 
MEDLINE, and EconLit. We selected original research articles for abstracting the evidence on 
cost-effectiveness of interventions, cost savings and the costs of intervention implementation.
Results—From the 53 references obtained from the literature search, we identified 11 original 
research articles that provided relevant information on the medical cost savings, implementation 
costs, or cost-effectiveness of interventions to reduce sodium intake. The interventions were low 
in cost, e. g., one study showed that the cost ranged from US$ 0.03 to 0.32 per person per year for 
awareness campaign through mass media outlets and government regulations on food products in 
low and middle-income countries. Population-wide interventions for salt reduction are very cost-
effective such as only ARS$ 151 per disability-adjusted life-year (DALY) saved in Argentina, 
whereas statin therapy to lower high cholesterol was $ 70 994 per DALY saved. Another study 
showed that sodium reduction could save US$ 18 billion in annual US healthcare costs by 
reducing sodium intake to 2300 mg/day.
Conclusion—The literature provided economic evidence that was in favor of population-wide 
interventions designed to reduce sodium intake. Reducing the intake of sodium through such 
initiatives might be one of the best buys in public health. However, the small body of literature 
and hypothetical scenarios in most studies might limit policy implications of the findings.
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Introduction
High blood pressure, the leading risk factor for mortality worldwide, contributes to a 
substantial number of premature deaths and acts to increase the incidence of a variety of 
cardiovascular and renal diseases, including stroke, coronary heart disease, heart failure, and 
kidney failure [1–4]. A high intake of sodium increases blood pressure and the risk of 
cardiovascular disease [5]. It has been shown that significant population-based reductions in 
sodium consumption could lower the blood pressure of enough people to yield a very large 
public health benefit in both developed and developing countries. Indeed, even a modest 
reduction in the population intake of sodium worldwide could produce a major improvement 
in public health [3,6]. Accordingly, population reductions in dietary sodium are 
recommended by a variety of major scientific and public health organizations [2,7–12]. In 
addition, some studies have shown the cost-effectiveness of interventions for sodium 
reduction. However, a comprehensive review of the evidence on cost-effectiveness has not 
been available. Such a review may facilitate the use of such evidence by policy makers in 
promoting activities to reduce sodium intake.
Because resources are limited, not all potentially beneficial interventions can be funded, that 
is, choices must be made in allocating scarce resources. Correspondingly, whether 
healthcare resources are used efficiently is an important factor for policy makers to consider 
in making such decisions. Specifically, which interventions are possibly effective and, more 
important, which interventions are economically justifiable, that is, their costs are lower than 
their benefits? But even if the costs are lower than the benefits, there is still a need to 
compare these costs and benefits with those of other programs to judge whether the 
investment in the interventions is the best use of the resources [13–16]. Economic 
evaluations can help inform decisions regarding the allocation of resources by comparing 
the costs and consequences of various interventions, and thus such evaluations can have 
considerable utility. For this study, we investigated which of the interventions designed to 
reduce sodium intake have been scientifically evaluated from an economic perspective, and 
we examined the evidence that these interventions are or are not cost-effective. To do this, 
we summarized the scientific evidence for the cost-effectiveness of interventions described 
in peer-reviewed articles published in the past decade. Our results will potentially assist 
policy makers in allocating scarce resources, and the findings should facilitate the process of 
implementing population-wide interventions to reduce sodium intake and control 
hypertension.
Methods
We searched the databases of PubMed, EMBASE, and EconLit using the key terms costs, 
cost-effectiveness, cost-benefit, cost-utility, and medical expenditures, and we combined the 
key terms sodium and salt with reduction, intake, and consumption. We limited the search to 
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English-language publications from January 2000 to May 2010. In addition to searching the 
four databases, we performed some searches through Google Scholar and searched the 
bibliographies of the articles obtained from the electronic searches for further relevant 
articles. We included cost analyses in this review even though they are not cost-
effectiveness analyses by strict definition, because the evidence about costs is a key element 
in evaluating cost-effectiveness, and policy makers and interventionists can benefit from 
such information if cost-effectiveness is not readily available.
We first reviewed the titles and abstracts of the collected literature to select potentially 
relevant studies, and then we carefully reviewed the abstracts and entire studies to decide on 
the final set of literature for synthesizing the evidence on cost-effectiveness. We required 
that either the costs of intervention or savings in medical costs be presented. We also 
required that the study be original research and contain a study design and its own data 
analysis, and thus editorials and letters, review articles, commentary, and publications 
reviewing research highlights were not included.
We analyzed the literature for developed (high income) and developing (low and middle 
income) countries separately. The low-income and middle-income economies were defined 
by the World Bank [17]. In addition to the differences between such countries in 
socioeconomic status, in most developed countries, dietary sodium mainly comes from the 
addition of salt to processed foods while they are being manufactured, whereas in 
developing countries most dietary salt comes from salt added during cooking or from sauce 
[6]. Such differences may indicate a need for different strategies or policy-making processes 
in efforts to reduce sodium intake.
Results
The literature search provided 53 references; after screening their titles and abstracts, we 
selected 16 for a critical review. From this group, we identified 11 original research articles 
that evaluated interventions from an economic perspective and provided relevant evidence 
on cost-effectiveness (Fig. 1). Of these 11 studies, eight evaluated interventions in 
developed countries, two in developing countries, and one in both kinds of countries (Table 
1). Nine of the 11 studies were published in 2006 or later. In conducting the analysis, some 
studies only considered medical cost saving from sodium-reduction interventions, whereas 
others investigated the costs of intervention implementation.
Developed countries
Smith-Spangler et al. [18] (US) assessed the cost-effectiveness of two different population 
strategies that were intended to reduce intake of sodium: collaboration of the government 
with food manufacturers to voluntarily reduce sodium in processed foods, and a tax on 
sodium (Table 2). For US adults aged 40–85 years, collaboration with industry that 
decreased mean intake of sodium by 9.5% was estimated to avert 513 885 strokes and 480 
358 myocardial infarctions over their lifetimes and to save US$ 32.1 billion in annual 
medical costs. Over the same period, a tax on sodium that decreased the population’s intake 
of sodium by 6% was projected to save US$ 22.4 billion in such costs. The authors 
concluded that population-based strategies for salt reduction in the US would reduce 
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substantially the incidence of both stroke and myocardial infarction, thereby saving billions 
of dollars in expenses for medical care. They also demonstrated that collaboration with 
industry to establish voluntary sodium targets in processed food would be more cost-
effective than a tax on sodium and would be an appropriate first step toward reducing 
population intake of sodium and the burden of cardiovascular disease.
Bibbins-Domingo et al. [19] (US) employed Markov modeling applied to US residents aged 
35 years or older to assess the impact of reducing dietary salt by 3 g per day on the annual 
number of new cases of coronary heart disease, stroke, and myocardial infarction and on 
reducing annual deaths from any cause. These researchers found that a regulatory 
intervention targeting a daily reduction of 3 g of salt would save, on an annual basis, 194 
000 to 392 000 quality-adjusted life-years (QALYs) and US$ 10–24 billion in healthcare 
costs. Such an intervention would save costs even if the reduction was just 1 g per day, 
achieved on a gradual basis between 2010 and 2019, and it would be more cost-effective 
than a program of using drugs to lower blood pressure in the entire hypertensive population. 
The expected decreases in cardiovascular events from a reduction in dietary salt of 3 g per 
day would be either similar in magnitude or greater than those projected for interventions 
targeting tobacco or obesity, interventions involving primary prevention with statins, and the 
pharmacologic treatment of hypertension.
Palar and Sturm [20] (US) calculated the potential savings to society from reducing the rates 
of hypertension and related cardiovascular disease by lowering the population’s sodium 
intake; this study used a cross-sectional simulation approach to model various scenarios. The 
authors found that reducing average sodium intake to 2300 mg/day might eliminate 11 
million cases of hypertension, save US$ 18 billion in healthcare costs, and gain 312 000 
QALYs valued at US$ 32 billion on an annual basis. The authors concluded that society 
may gain large benefits from efforts to lower the consumption of salt over time.
In two studies, Dall et al. [21,22] (US) used a simulation model to predict the health benefits 
(saving in medical costs) or gains in productivity under hypothetical scenarios for dietary 
change among US adults that included reduced intake of sodium. The authors found that 
long-term reductions in sodium intake of 400 mg/day in those with uncontrolled 
hypertension would eliminate about 1.5 million hypertension cases, which per year would 
save US$ 2.3 billion and potentially increase productivity by US$ 2.5 billion.
Joffres et al. [23] (Canada) estimated the impact of dietary sodium reduction on the 
prevalence of hypertension and medical cost savings. The authors found that the sodium 
reduction of 1840 mg/day might decrease the prevalence of hypertension by 30%, which in 
Canada would mean a reduction of 1 million hypertensive patients, and it would almost 
double the rates of treatment and control for hypertensive persons. The authors estimated 
direct cost savings from fewer physician visits and laboratory tests and less use of drugs to 
be about US$ 430 million annually. They also estimated that the total costs of physician 
visits and laboratory services would decrease by 6.5% and predicted that among patients 
receiving treatment for hypertension, 23% fewer would need drugs to control their blood 
pressure.
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Kristiansen et al. [24] (Demark) conducted a face-to-face interview survey in 2000 on a 
random sample (n = 924) of Danish people aged 20–74 years in which they asked 
participants how much they would be willing to pay as an additional tax for a population 
program that would cut the intake of salt in half. The aggregated willingness to pay was $ 
468 million (in US dollars), more than three times the annual program cost (net) of $ 148 
million. Although only 57% of the population was willing to pay, the authors found that 
such a program was warranted from an economic perspective.
Selmer et al. [25] (Norway) estimated the economic and health consequences (reduced risk 
of myocardial infarction and stroke because of lowered blood pressure) of interventions 
designed to reduce individual daily sodium intake in the Norwegian population by 6 g. 
Health promotion (informational campaigns), the development by industry of new recipes 
for foods, reporting the salt content of foods, and levying taxes on salty food/providing 
subsidies for products with less salt were the possible interventions. The net cost of the 
interventions (discounted at 5%) was minus US$ 118 million (i.e. they were cost saving). 
Thus, the costs of population interventions were lower than the cost savings from fewer 
strokes and heart attacks.
Developing countries
Rubinstein et al. [15] (Argentina) identified the most efficient of a variety of interventions, 
including reducing the amount of salt in bread, for decreasing cardiovascular disease (Table 
3). The average cost-effectiveness ratio [measured in Argentine pesos (ARS $) per DALY 
saved for the interventions was as follows: reducing salt in bread, $ 151; a mass-media 
campaign, $ 547; combination pharmacotherapy for participants who had a 20, 10, and 5% 
global risk of cardiovascular disease, $ 3599, 4113, and 4533, respectively; therapy to lower 
blood pressure, $ 7716; tobacco cessation using the drug bupropion, $ 33 563; and statin 
therapy to lower high cholesterol, $ 70 994. Using the average per capita income in 
Argentina, the two population-based interventions that were chosen for analysis (reducing 
salt in bread and providing health education through mass-media campaigns) and the 
pharmacotherapy strategy targeting people with a 20% or greater risk of cardiovascular 
disease were cost-effective.
Asaria et al. [26] (23 low-income to middle-income countries), who investigated how many 
deaths might be avoided over 10 years by implementing certain population-based 
interventions, calculated the costs of implementation using methods from the World Health 
Organization’s Comparative Risk Assessment project. In this analysis, salt intake would be 
reduced by 15% over 10 years in 23 countries in low and middle-income regions of the 
world. The main costs of the strategy would be an awareness campaign carried out through 
mass-media outlets and the regulation of food products by public health officers, with a total 
cost ranging from US$ 0.04 to 0.32 per person. This intervention could be implemented 
without great cost or structural change to the health system and could make a major 
contribution to reducing the death rate from chronic diseases.
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Both developed and developing countries
Murray et al. [3] (Southeast Asia, Latin America, and Europe) estimated health effects at the 
population level and the costs of specific interventions to reduce the risks associated with 
high cholesterol and elevated blood pressure in areas of the world that had different 
epidemiological profiles (Table 3). Nonpersonal health interventions – among them action 
by government to stimulate a lowering of the salt content of processed foods – were found to 
be cost-effective in limiting cardiovascular disease and could avoid the loss of over 21 
million DALYs annually around the world. The combination of personal and non-personal 
health interventions they evaluated could reduce the incidence of cardiovascular events 
worldwide by as much as 50%.
Discussion
We found that all 11 of the original research studies published in the past decade provided a 
significant amount of economic evidence in favor of interventions to reduce sodium intake. 
Notably, all of the interventions evaluated from an economic perspective were population-
based initiatives. The results show that they were either low in cost, provided benefits higher 
than their costs, or were more cost-effective than other interventions. Among eight studies 
that dealt with developed countries, six were from the US and Canada, and two were from 
Europe (Denmark and Norway). Interestingly, all six US and Canadian studies evaluated salt 
reduction from the point of view of savings in medical costs (some took at least one 
additional perspective), but no options for implementation or strategies were investigated. In 
contrast, the two European studies evaluated the costs of implementation. Similarly, of the 
three studies that included one or more developing countries, two evaluated how much the 
implementation would cost. Thus, in the US and Canada, information on how to implement 
interventions and what resources might be required is lacking. Accordingly, future research 
on how to implement interventions might be important in achieving the goals of sodium 
reduction in these countries. In this regard we note that one author, Sugarman [11], proposed 
an innovative strategy in the US that is relevant to salt reduction. He proposed performance-
based regulation to require food retailers (supermarkets and restaurants) to reduce the 
overall amount of salt contained in the foods they sold over time; in Sugarman’s proposal, 
this would be measured by grams of salt per dollar volume of sales.
Another characteristic of the 11 studies that we examined in detail was their relative 
recency, with nine published in 2006 or later, even though our time frame began in 2000. 
Furthermore, six of the 11 studies were based in the US or Canada. These findings may 
suggest that the high content of sodium in the diets of both Americans and Canadians has 
become better recognized as an important public health issue in recent years.
At present there is a clear need, especially in developing countries, for information on the 
cost and cost-effectiveness of initiatives to reduce sodium intake. For example, a study [10] 
of an intervention in China claimed that it was a low-cost strategy, but there was no 
information on cost in that study. Another study [12], in New Zealand, suggested that 
lowering the amount of salt in bread is a cost-effective way to reduce population-wide blood 
pressure, but again we could find no information on cost in the study. This lack of 
information on cost may limit the policy implications of these studies. Another concern 
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about the literature we reviewed is that all the studies used adults or the general population 
as study participants; no studies assessed salt intake in children and adolescents. And yet, 
interventions targeting children and adolescents have high expected benefits that are 
generally attributed to ‘early’ prevention [27]. The literature has suggested that a moderate 
reduction in salt intake in children causes immediate falls in blood pressure and, if 
continued, may well less the subsequent rise in blood pressure with age [28].
Limitations
In addition to the strengths and weaknesses of the literature summarized in Table 4 and the 
information we obtained from the 11 studies notwithstanding, some limitations should be 
considered in interpreting our findings from the literature. First, ‘publication bias’ may have 
been present; we could review only what has been published. Studies that report favorable 
results are more likely to get published, and thus there is a tendency to overestimate the 
efficiency and effectiveness of the interventions in question. Additionally, we searched only 
four literature databases, and those only from 2000 to May 2010. Thus, we may have missed 
important evidence (from the grey literature, for example). Second, we did not explore 
healthcare systems across countries in our study, which was organized by high and low-
income countries. This approach may have limited the use of our results for the 
establishment of health policy and for deciding how to allocate resources, as it may be hard 
to generalize the health economic data across countries. Finally, we did not formally address 
the issue of the analytic approaches chosen in terms of their potential value to readers. For 
example, studies from the US and Canada evaluated the impact of sodium reduction from 
the perspective of savings in medical costs, but the issues of which intervention strategies 
were feasible and the associated costs of implementation were not investigated. 
Additionally, all six US and Canadian studies used simulation models under hypothetical 
scenarios rather than data on the actual intervention to evaluate the approaches to sodium 
reduction. Thus, the policy implications of the study findings might be limited.
Implications for policy
The economic evidence we obtained in this study clearly favors the use of population-wide 
interventions to reduce sodium intake around the world. Policy makers could use such 
information in setting their priorities for choosing or funding interventions. The next 
question is how to inform policy makers about the available evidence. In this regard, we see 
a need for research to explore the extent to which the available economic evidence informs 
policy making. In addition, further studies of the cost-effectiveness of various strategies to 
achieve sodium reduction, and an understanding of what is involved in implementing these 
strategies, are needed to scale up the population-wide interventions.
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Diagram for selecting the studies on the cost-effectiveness of interventions to reduce sodium 
intake.
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Table 2
Cost-effectiveness of interventions in developed countries to reduce sodium intake
1st author, year/analysis type/country Populations /interventions Study design and methods Main results
Smith-Spangler 2010/cost-effectiveness/US Adults aged 40–85 years/
population-based: government 
collaboration with food 
industry versus sodium tax
Markov model constructed 
with four health states: well, 
AMI, acute stroke, history of 
AMI or stroke
Government 
collaboration with food 
manufacturers is more 
effective than a tax on 
sodium, although both 
programs would 
improve health and 
save billions of dollars.
Bibbins-Domingo 2010/cost-effectiveness/US US residents aged 35 years of 
age or older/population-based 
program
Markov modeling (computer 
simulation, state-transition 
model)
Reduction in salt intake 
of 3 g/day saves US
$10 to $24 billion in 
annual medical costs. It 
would be more cost-
effective than using 
drugs to control 
hypertension for 
everyone with that 
disorder.
Palar 2009/medical cost savings, QALYs 
gained/US
Noninstitutionalized US adults 
aged 18 and older/population-
based program
Cross-sectional simulation/
health outcomes: cases of 
hypertension and QALYs
Reducing sodium 
intake to 2300 mg/day 
may result in 11 
million fewer cases of 
hypertension, reduce 
medical costs by US
$18 billion, and gain 
312 000 QALYs 
(valued at US$32 
billion) annually.




Reduction in sodium 
intake of 400 mg/day 
in hypertensive persons 
would result in 1.5 
million fewer cases 
annually, saving US
$2.3 billion.




Reductions in sodium 
intake of 400 mg/day 
in hypertensive persons 
would increase annual 
productivity by US$ 
2.5 billion.
Joffres 2007/medical costs savings/Canada 23 129 individuals from the 
Canadian Heart Health 
Surveys/population-based 
program
Obtaining information from 




reduced prevalence of 
hypertension and saved 
substantial medical 
costs (US$430 million 
in direct costs; 
physician visits and 
laboratory costs 
decreased by 6.5%).
Kristiansen 2006/willingness to pay/Denmark Random sample of Danish 
adults (n = 924) aged 20–74 
years/population-based 
program
Contingent valuation through 
computer-assisted personal 
interviewing
The annual net 
program cost was US
$148 million, less than 
the aggregate 
willingness to pay of 




Selmer 2000/cost of interventions versus 
medical cost savings/Norway
Aged 40 and older/population-
based program
Dynamic simulation model The costs of the 
population 
interventions will be 
offset by cost savings 
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1st author, year/analysis type/country Populations /interventions Study design and methods Main results
from fewer strokes and 
heart attacks.
AMI, acute myocardial infarction; CVD, cardiovascular disease; QALY, quality-adjusted life-year.
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Table 3
Cost-effectiveness of interventions in developing countries to reduce sodium intake
1st author, year/analysis 
type/country





Over 3 million people in Buenos 
Aires, Argentina/population and 
individual-based salt programs
WHO-CHOICE methodology The population-based reduction in 
the amount of salt in bread was 
most cost-effective (ARS$ 151 per 
DALY saved) among the analyzed 
interventions.
Asaria 2007/deaths 
averted versus cost of 
implementation/23 low-
income or middle-income 
countries
General population in 23 low-income 
and middle-income countries (no 
specific population mentioned)/
population-based program
WHO comparative risk 
assessment
The population-based salt reduction 
could be implemented without great 
cost (US$ 0.04 to 0.32 per person 
year) or structural change (in the 
health system) and could greatly 
reduce the death rate from chronic 
diseases.
Murray 2003/costs of 
selected interventions, 
health effects/southeast 
Asia, Latin America, and 
Europe
General population (no specifics 
provided)/population-based program
Methods taken from WHO-
CHOICE project
Government action to stimulate a 
reduction in the amount of salt 
contained in processed foods is 
cost-effective for limiting 
cardiovascular disease.
ARS $, Argentine pesos; DALY, disability-adjusted life-year, WHO, World Health Organization, WHO-CHOICE, World Health Organization-
choosing interventions that are cost-effective.
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Table 4
Strengths and weaknesses of the literature
Countries Strengths Weakness
United States and Canada (six studies) Employed advanced mathematical modeling. Lack of specific intervention strategies.
Used high-quality data on health and medical costs. Lack of costs for implementing interventions.
Rest of the world (five studies) Evaluated specific interventions. Lack of data on health and medical costs.
Analyzed costs of implementation.
Overall (11 studies) All studies evaluated population-wide interventions. Not a complete cost-effectiveness analysis.
All focused on general population.
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